Cancer, Sickle Cell, and Migraines

View in Browser  

Hi EL,

Earlier this year, Pfizer announced our renewed commitment to oncology and our strengthened commitment to creating the next generation of breakthroughs in the fight against cancer. Recently, we showcased some of the latest developments, and a multi-modality approach, in our efforts to tackle this modern scourge. Dive into our research with this month's featured story.

Pfizer also aims to improve treatment and care for those who suffer from the thousands of "rare diseases" that aren't as common as cancer. There are millions of people whose afflictions are far less well-known, and they deserve to be seen. For Rare Disease Day, we partnered with a renowned Black British choir to shed light on sickle cell disease, which affects approximately 100,000 people in the USA. Listen to their song about what it's like to live with the disease.

Rare Disease Day wasn't the only notable event in February, as Pfizer employees around the country celebrated and recognized Black History Month. Events held across multiple Pfizer locations included discussions, panels, and community-based gatherings that embraced the legacy of Dr. Martin Luther King Jr. and paid tribute to those who have helped shape the past, present, and future of the Black community. Read about our month-long celebration.

Migraines aren't seasonal, and with one in seven people suffering from them, they can have a disruptive impact on your workplace. Thankfully, there are many policies that companies can implement to make work more migraine friendly.

Learn what they are, and why they're necessary.

Finally, catch up with Pfizer on social media via our monthly round-up. This month, CEO Albert Bourla celebrates International Women's Day and the one-year anniversary of Pfizer's School of Science, and our TikTok channel tackles medical misinformation. See what you missed!

Thanks for reading! 

A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs

Cancer cells are extremely tough to outwit, continually changing their genetic makeup in order to survive, multiply, and spread. Cancer treatment is not “one-size-fits-all", and we have learned that we must attack tumors from multiple angles. Pfizer scientists are using their deep technical expertise to develop next-generation cancer therapies to do just that.

Pfizer Teams With Black British Choir to Bring Awareness to Sickle Cell, Rare Diseases

Every year on Rare Disease Day, Pfizer spotlights illnesses that don't always get noticed. Learn about our partnership with a Black British choir to shed light on the experience of living with sickle cell disease.

Pfizer Celebrates Legacy, Justice, and Equity

Black History Month at Pfizer began with an acknowledgment of how our Black colleagues are actively shaping our future and continued with multiple events across the company. Read about the different ways we celebrated.

Migraine in the Workplace and Creating a Safe Space

One billion people worldwide live with migraine, but it is often not discussed—especially in the workplace. Discover migraine-friendly work policies and the positive impact they can have on the workplace.

Pfizer on Social Media - March Round-up

Stay abreast of the ways Pfizer is breaking through the noise with this monthly recap of our thought leaders’ most thought-provoking posts and prominent mentions of Pfizer across social media.  

This content is intended only for a US audience. You're receiving this email because you previously signed up for the Pfizer, Get Healthy Stay Healthy, or Breakthroughs newsletter.

To subscribe to specific topics or content types or to receive automated alerts of newly published content from Pfizer.com, visit Pfizer's Subscription Center.

If you no longer wish to receive professional marketing email communications from Pfizer, unsubscribe here.

Please do not reply as this is an unattended email box. 

Pfizer Inc.

66 Hudson Boulevard

New York, NY 10001

© 2023 Pfizer Inc. All Rights Reserved.